[Administration of aclarubicin in malignant lymphoma].
作者信息
Takagi T, Oguro M, Iwabuchi K
出版信息
Gan To Kagaku Ryoho. 1983 Jun;10(6):1540-1.
PMID:6575729
Abstract
摘要
相似文献
1
[Administration of aclarubicin in malignant lymphoma].[阿柔比星在恶性淋巴瘤中的应用]
Gan To Kagaku Ryoho. 1983 Jun;10(6):1540-1.
2
Clinical evaluation of a new anthracycline antibiotic, aclacinomycin-A, in patients with advanced malignant lymphoma.新型蒽环类抗生素阿克拉霉素-A治疗晚期恶性淋巴瘤患者的临床评估
Am J Clin Oncol. 1983 Feb;6(1):81-4.
3
[Aclacinomycin-A in acute leukaemias and leukaemic non-Hodgkin lymphomas (author's transl)].
Nouv Presse Med. 1982 Jan 9;11(1):25-8.
4
5
[New agents in the treatment of leukemia and lymphoma].
Gan To Kagaku Ryoho. 1983 Apr;10(4 Pt 2):1031-40.
6
[Intravesical instillation therapy of aclacinomycin-A (ACM) for superficial bladder tumor].
Hinyokika Kiyo. 1984 Sep;30(9):1153-8.
7
Phase I-II study of aclarubicin for treatment of acute myeloid leukemia.阿柔比星治疗急性髓系白血病的I-II期研究
Cancer Treat Rep. 1984 Jun;68(6):881-6.
8
Clinical phase I study of aclacinomycin A by evaluation of an intermittent intravenous administration schedule.
Cancer Res. 1981 Jun;41(6):2417-20.
9
[Evaluation of aclacinomycin-A in head and neck cancer].[阿克拉霉素-A治疗头颈部癌的评估]
Gan To Kagaku Ryoho. 1984 Nov;11(11):2335-41.
10
[Effects of single administration of tetrahydropyranyladriamycin (THP) in lymphoid malignancy].[四氢吡喃阿霉素（THP）单次给药对淋巴系统恶性肿瘤的影响]
Gan To Kagaku Ryoho. 1984 Jul;11(7):1450-6.
Zotero 插件